Thursday, August 14, 2008
Genomics making warfarin easier to manage
Warfarin is a very challenging drug to prescribe and manage. Not only is the therapeutic window narrow, but achieving the correct dose and maintaining a stable international normalized ratio (INR) for patients can be problematic. Any reasonably cost- and time-effective improvement in warfarin management would be welcomed by most clinicians.
Over the last several years new genetic tests for variants in the CYP2C9 and VKORC1 genes have been developed that predict a substantial component of warfarin metabolism. Many scientists and academic health care providers feel that prospective use of these tests may save lives and health care resources. To date, several small studies comparing the use of genetic testing to standard of care have produced mixed results. There may be evidence for reduced use of blood draws for INRs and office visits, but no large trial has demonstrated a mortality benefit. The FDA has altered warfarin's labeling to reflect this new information.
A number of companies and health care systems already have geared up to offer warfarin pharmacogenetic tests with a rapid turn-around time. The National Heart, Lung and Blood Institute of the National Institutes of Health started a major trial of warfarin pharmacogenetic testing through the University of Pennsylvania, which should greatly enhance our understanding of the clinical utility of such tests.
Interestingly, the Centers for Medicare and Medicaid Services opened a National Coverage Analysis (NCA) of the topic. The public comment for this NCA runs until Sept. 3. For some in the personalized medicine community, this NCA is viewed as a critical test case of personalized medicine predicated on genomic information. Perhaps this overstates the situation. It probably is best viewed as an opportunity for a much-needed dialogue between supporters of personalized medicine and evidence-based medicine.
Will the nation's largest health care payer accept the current evidence supporting the use of warfarin pharmacogenetic testing in routine care? A recent review using the Rapid ACCE format by McClain et al. raised serious concerns regarding gaps in the current evidence base. However, this is a rapidly moving field and more data are now available.
In a time of rapid advances in genetics and genomics and spiraling health care costs, any significant "evidentiary gap" will be increasingly problematic for promising and potentially very significant improvements in standard of care. Substantial resources should be directed at re-tooling our research and health care delivery systems to rapidly and responsibly generate the types of effectiveness data needed to separate the wheat from the chaff in genomics, and more broadly, all emerging health care technologies.
W. Gregory Feero, MD, PhD, a family physician with a doctorate in human genetics, is senior adviser for genomic medicine in the Office of the Director at the NIH's National Human Genome Research Institute. His column runs every issue in ACP Internist
Labels: genetics, genomics, Practical Genomics
posted by W. Gregory Feero, MD, PhD at
9:14 AM
Contact ACP Internist
Send comments to ACP Internist staff at acpinternist@acponline.org.
Previous Posts
- Sad stories about health coverage
- Alcohol use and PTSD in veterans
- Medical news of the obvious
- Got a patient taking a trip to Africa?
- What do patients want?
- Fighting HIV with drugs and nurses
- TB or not TB
- Medical news from overseas
- FDA's new conflict-of-interest guidelines
- Medical News of the Obvious
Blog log
Members of the American College of Physicians contribute posts from their own sites to ACP Internist and ACP Hospitalist. Contributors include:
Albert
Fuchs, MD
Albert Fuchs, MD, FACP, graduated from the
University of California, Los Angeles School of Medicine, where he
also did his internal medicine training. Certified by the American
Board of Internal Medicine, Dr. Fuchs spent three years as a
full-time faculty member at UCLA School of Medicine before opening
his private practice in Beverly Hills in 2000.
Zackary
Berger
Zackary Berger, MD, ACP Member, is a primary care
doctor and general internist in the Division of General Internal
Medicine at Johns Hopkins. His research interests include
doctor-patient communication, bioethics, and systematic reviews.
CasesBlog
Ves
Dimov, MD, ACP Member, is an allergist/immunologist and Assistant
Professor of Medicine and Pediatrics at the University of Chicago,
where he evaluates and treats both pediatric and adult patients.
David
Katz, MD
David L. Katz, MD, MPH, FACP, is an internationally
renowned authority on nutrition, weight management, and the
prevention of chronic disease, and an internationally recognized
leader in integrative medicine and patient-centered care.
db's
Medical Rants
Robert M. Centor, MD, FACP,
contributes short essays contemplating medicine and the health care
system.
DrDialogue
Juliet
K. Mavromatis, MD, FACP, provides a conversation about health topics
for patients and health professionals.
Dr.
Mintz' Blog
Matthew Mintz, MD, FACP, has practiced internal
medicine for more than a decade and is an Associate Professor of
Medicine at an academic medical center on the East Coast. His time is
split between teaching medical students and residents, and caring for
patients.
Everything
Health
Toni Brayer, MD, FACP, blogs about the rapid
changes in science, medicine, health and healing in the 21st century.
FutureDocs
Vineet
Arora, MD, FACP, is Associate Program Director for the Internal
Medicine Residency and Assistant Dean of Scholarship & Discovery
at the Pritzker School of Medicine for the University of Chicago. Her
education and research focus is on resident duty hours, patient
handoffs, medical professionalism, and quality of hospital care. She
is also an academic hospitalist.
Glass
Hospital
John H. Schumann, MD, FACP, provides
transparency on the workings of medical practice and the complexities
of hospital care, illuminates the emotional and cognitive aspects of
caregiving and decision-making from the perspective of an active
primary care physician, and offers behind-the-scenes portraits of
hospital sanctums and the people who inhabit them.
Gut
Check
Ryan Madanick, MD, ACP Member, is a gastroenterologist
at the University of North Carolina School of Medicine, and the
Program Director for the GI & Hepatology Fellowship Program. He
specializes in diseases of the esophagus, with a strong interest in
the diagnosis and treatment of patients who have difficult-to-manage
esophageal problems such as refractory GERD, heartburn, and chest
pain.
I'm
dok
ACP Member Mike Aref, MD, PhD, ACP Member, is an academic
hospitalist with an interest in basic and clinical science and
education, with interests in noninvasive monitoring and diagnostic
testing using novel bedside imaging modalities, diagnostic reasoning,
medical informatics, new medical education modalities, pre-code/code
management, palliative care, patient-physician communication, quality
improvement, and quantitative biomedical imaging.
Informatics
Professor
William Hersh, MD, FACP, Professor and Chair,
Department of Medical Informatics & Clinical Epidemiology, Oregon
Health & Science University, posts his thoughts on various topics
related to biomedical and health informatics.
Just
Oncology
Richard Just, MD, ACP Member, has 36 years in
clinical practice of hematology and medical oncology. His blog is a
joint publication with Gregg Masters, MPH.
KevinMD
Kevin
Pho, MD, ACP Member, offers one of the Web's definitive sites for
influential health commentary.
MD
Whistleblower
Michael Kirsch, MD, FACP, addresses
the joys and challenges of medical practice, including controversies
in the doctor-patient relationship, medical ethics and measuring
medical quality. When he's not writing, he's performing
colonoscopies.
Medical
Lessons
Elaine Schattner, MD, ACP Member, shares
her ideas on education, ethics in medicine, health care news and
culture. Her views on medicine are informed by her past experiences
in caring for patients, as a researcher in cancer immunology, and as
a patient who's had breast cancer.
More
Musings
Rob Lamberts, MD, ACP Member, a med-peds and general
practice internist, returns with "volume 2" of his personal
musings about medicine, life, armadillos and Sasquatch at More
Musings (of a Distractible Kind).
Musing
of an Internist
Justin Penn, MD, ACP Associate Member,
attended medical school at the University of Washington School of
Medicine and trained in internal medicine at the University of
Rochester, where he is serving as Chief Resident.
Prescriptions
David
M. Sack, MD, FACP, practices general gastroenterology at a small
community hospital in Connecticut. His blog is a series of musings on
medicine, medical care, the health care system and medical ethics, in
no particular order.
Reflections
of a Grady Doctor
Kimberly Manning, MD, FACP,
reflects on the personal side of being a doctor in a community
hospital in Atlanta.
Technology
in (Medical) Education
Neil Mehta, MBBS, MS, FACP,
is interested in use of technology in education, social media and
networking, practice management and evidence-based medicine tools,
personal information and knowledge management.
White
Coat Underground
Peter A. Lipson, MD, ACP Member, is a
practicing internist and teaching physician in Southeast Michigan.
The blog, which has been around in various forms since 2007, offers
musings on the intersection of science, medicine, and culture.
Other blogs of note:
American
Journal of Medicine
Also known as the Green
Journal, the American Journal of Medicine publishes original clinical
articles of interest to physicians in internal medicine and its
subspecialities, both in academia and community-based practice.
Clinical
Correlations
A collaborative medical blog started
by Neil Shapiro, MD, ACP Member, associate program director at New
York University Medical Center's internal medicine residency program.
Faculty, residents and students contribute case studies, mystery
quizzes, news, commentary and more.
Interact
MD
Michael Benjamin, MD, ACP member, doesn't accept
industry money so he can create an independent, clinician-reviewed
space on the Internet for physicians to report and comment on the
medical news of the day.
PLoS
Blog
The Public Library of Science's open access
materials include a blog.
White
Coat Rants
One of the most popular anonymous blogs
written by an emergency room physician.
2 Comments:
Thanks for writing this post. You made all the right connections that I didn't see until now.
I think we are missing the bus on warfarin testing.
I am a practicing hematologist. I cannot fathom what the benefit of warfarin genetic testing is supposed to be.
I am a proponent of genetic testing. I believe that BRCA testing saves lives, and I send a lot of tests. I have lectured to community groups about the importance of BRCA testing.
I think there's a huge difference between that and warfarin testing. We already have a well-established clinical platform for dosing and adjusting warfarin dosing: INR testing. INR tests are rapid, cheap, and are well-correlated to bleeding risk.
We already know that we have to follow some patients more carefully on warfarin; that fact becomes clinically evident in short order. Labile INRs in my office are followed with shorter intervals of testing, and that would be true regardless of the result of genetic testing. So I fail to see the added value of testing.
I would like to see a study where patients were managed differently according to warfarin genetic testing, and that the outcomes were improved. So far, there hasn't been such a paper.
Finally, in the specific case of warfarin, we are expecting the approval of two if not three new oral anticoagulants that will not require any INR testing at all. Warfarin genetic testing is solving a clinical problem that may not exist in a few years.
I would prefer we devote our precious health research resources to creating tests that actually benefit doctors and patients, not just ones that enrich the testing companies.
InteractMD.com
Post a Comment
Subscribe to Post Comments [Atom]
<< Home